更新基因治疗临床试验对眼睛疾病的最新情况
Nicolas Lonfat1, Laura Moreno-Leon1, Claudio Punzo2
1Astellas Pharma Inc., Westborough, Massachusetts, USA.
Human gene therapy
|September 18, 2025
概括
基因疗法为遗传性视网膜疾病提供了有前途的新疗法,如视网膜色素炎和黄斑变性. 目前的临床试验显示了基因特异性和基因不可知性方法的潜力,以恢复视力和对抗失明.
科学领域:
- 眼科和遗传学 眼科和遗传学
- 视网膜退行性疾病 视网膜退行性疾病
- 基因治疗的应用 基因治疗的应用
背景情况:
- 在全球范围内,遗传性和复杂的视网膜疾病导致显著的不可逆转的视力丧失.
- 遗传异质性和复杂的机制阻碍了有效的疾病修饰治疗.
- 目前对视网膜色素炎,与年龄相关的黄斑变性和绿眼等疾病的治疗选择有限.
研究的目的:
- 审查当前的基因治疗策略,以治疗视网膜疾病.
- 提供关于视网膜基因疗法的正在进行和已完成的临床试验的最新信息.
- 讨论基于基因的新型治疗方法的疗效和输送方法.
主要方法:
- 对临床试验的审查,重点是基因特异性和基因不可知基因疗法方法.
- 对复合腺相关病毒载体 (AAV) 中介的基因传递方法的分析.
- 评价基因编辑技术和眼科治疗中的反感性寡核酸应用.
- 对眼部输送路径的评估: 上腺, 内腺和上腺.
主要成果:
- 最初的临床试验数据表明,各种基因疗法传递方法的可行性.
- 再组合的AAV载体正在被用于传递完整的基因或基因编辑组件.
- 早期的结果表明,在不同的眼部输送策略中具有潜在的有效性.
结论:
- 基因疗法显示出显著的潜力,可以彻底改变视网膜疾病的管理.
- 需要进一步的长期临床数据和精细的终点来确认疗效,安全性和耐用性.
- 基因治疗对患有衰弱视网膜疾病的患者来说是一个有前途的途径.
相关概念视频
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Glaucoma: Overview
1.3K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.3K


